Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

被引：0
|
作者：
Majd Issa
Brett G. Klamer
Nikol Mladkova
Georgios I. Laliotis
Vidhya Karivedu
Priyanka Bhateja
Chase Byington
Khaled Dibs
Xueliang Pan
Arnab Chakravarti
John Grecula
Sachin R. Jhawar
Darrion Mitchell
Sujith Baliga
Matthew Old
Ricardo L. Carrau
James W. Rocco
Dukagjin M. Blakaj
Marcelo Bonomi
机构：
[1] The Ohio State University Wexner Medical Center,Department of Internal Medicine, Division of Medical Oncology
[2] The Ohio State University,Center for Biostatistics, Department of Biomedical Informatics
[3] The Ohio State University Wexner Medical Center,Division of Radiation Oncology
[4] Johns Hopkins University,Sidney Kimmel Comprehensive Cancer Center and Department of Oncology
[5] The Ohio State University Wexner Medical Center,Department of Otolaryngology
来源：
BMC Cancer | / 22卷
关键词：
Head and neck cancer; Head and neck squamous cell carcinoma; Immunotherpay; Immune checkpoint inhibitors; Survival in head and neck cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Patterns of Response to Immune Checkpoint Inhibitors in Association with Genomic and Clinical Features in Patients with Head and Neck Squamous Cell Carcinoma (HNSCC)
    Economopoulou, Panagiota
    Anastasiou, Maria
    Papaxoinis, George
    Spathas, Nikolaos
    Spathis, Aris
    Oikonomopoulos, Nikolaos
    Kotsantis, Ioannis
    Tsavaris, Onoufrios
    Gkotzamanidou, Maria
    Gavrielatou, Niki
    Vagia, Elena
    Kyrodimos, Efthymios
    Gagari, Eleni
    Giotakis, Evangelos
    Delides, Alexander
    Psyrri, Amanda
    CANCERS, 2021, 13 (02) : 1 - 15
  • [22] Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Papaxoinis, George
    Gavrielatou, Niki
    Anastasiou, Maria
    Pantazopoulos, Anastasios
    Kavourakis, George
    Gkolfinopoulos, Stavros
    Panayiotides, Ioannis
    Delides, Alexandros
    Psyrri, Amanda
    ORAL ONCOLOGY, 2020, 111
  • [23] Inhibition of PNCK inflames tumor microenvironment and sensitizes head and neck squamous cell carcinoma to immune checkpoint inhibitors
    Ding, Qin
    Weng, Youliang
    Li, Ying
    Lin, Wanzun
    Lin, Xiaosan
    Lin, Tingting
    Yang, Hanxuan
    Xu, Wenqian
    Wang, Jianming
    Ying, Hongmei
    Qiu, Sufang
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (10)
  • [24] Chemotherapy after immune checkpoint blockade in patients with recurrent, metastatic squamous cell carcinoma of the head and neck
    Kacew, Alec J.
    Harris, Ethan J.
    Lorch, Jochen H.
    Schoenfeld, Jonathan D.
    Margalit, Danielle N.
    Kass, Jason, I
    Tishler, Roy B.
    Haddad, Robert, I
    Hanna, Glenn J.
    ORAL ONCOLOGY, 2020, 105
  • [25] Lymph node ratio as a prognostic factor for survival in patients with head and neck squamous cell carcinoma
    Sano, Daisuke
    Yabuki, Kenichiro
    Takahashi, Hideaki
    Arai, Yasuhiro
    Chiba, Yoshihiro
    Tanabe, Teruhiko
    Nishimura, Goshi
    Oridate, Nobuhiko
    AURIS NASUS LARYNX, 2018, 45 (04) : 846 - 853
  • [26] Genomic and Molecular Profiling of Human Papillomavirus Associated Head and Neck Squamous Cell Carcinoma Treated with Immune Checkpoint Blockade Compared to Survival Outcomes
    Shaikh, Hira
    McGrath, Julie E.
    Hughes, Brittany
    Xiu, Joanne
    Brodskiy, Pavel
    Sukari, Ammar
    Darabi, Sourat
    Ikpeazu, Chukwuemeka
    Nabhan, Chadi
    Korn, Wolfgang Michael
    Wise-Draper, Trisha M.
    CANCERS, 2021, 13 (24)
  • [27] Combining Radiation and Immune Checkpoint Blockade in the Treatment of Head and Neck Squamous Cell Carcinoma
    Manukian, Gregor
    Bar-Ad, Voichita
    Lu, Bo
    Argiris, Athanassios
    Johnson, Jennifer M.
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [28] Survival in patients with recurrent squamous cell head and neck carcinoma treated with bio-chemotherapy
    Airoldi, M
    De Stefani, A
    Marchionatti, S
    Pedani, F
    Gabriele, P
    Ragona, R
    Cortesina, G
    Bumma, C
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2001, 23 (04): : 298 - 304
  • [29] Toxicity profiles of immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A systematic review and meta-analysis
    Dang, Shoutao
    Li, Xinyu
    Liu, Heshu
    Zhang, Shuyang
    Li, Wei
    CANCER MEDICINE, 2024, 13 (07):
  • [30] Immune checkpoint inhibitor use in head and neck squamous cell carcinoma: the current landscape and future perspectives
    Gatfield, Elinor R.
    Tadross, John
    Ince, William
    FUTURE ONCOLOGY, 2024, 20 (23) : 1695 - 1711
12345